Ritu Baral
Stock Analyst at TD Cowen
(2.76)
# 1,804
Out of 5,135 analysts
46
Total ratings
38.46%
Success rate
1.01%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ritu Baral
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRYS Krystal Biotech | Maintains: Buy | $202 → $306 | $283.29 | +8.02% | 1 | Jan 9, 2026 | |
| VTVT vTv Therapeutics | Initiates: Buy | $67 | $37.23 | +79.96% | 1 | Jan 5, 2026 | |
| INSM Insmed | Maintains: Buy | $269 → $241 | $151.11 | +59.49% | 7 | Dec 18, 2025 | |
| PVLA Palvella Therapeutics | Maintains: Buy | $97 → $133 | $79.60 | +67.09% | 3 | Dec 16, 2025 | |
| MIST Milestone Pharmaceuticals | Upgrades: Buy | $8 | $1.67 | +379.04% | 1 | Dec 15, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $251 → $353 | $328.93 | +7.32% | 1 | Dec 8, 2025 | |
| VERA Vera Therapeutics | Maintains: Buy | $60 → $73 | $44.07 | +65.65% | 2 | Dec 5, 2025 | |
| RNA Avidity Biosciences | Downgrades: Hold | $78 → $74 | $72.83 | +1.61% | 2 | Oct 29, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Buy | $35 → $39 | $23.19 | +68.18% | 2 | Sep 11, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $390 → $554 | $491.49 | +12.72% | 2 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.33 | - | 4 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.03 | - | 2 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $282 → $371 | $332.68 | +11.52% | 4 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.25 | - | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $175 | $18.38 | +852.12% | 1 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $53.48 | - | 2 | Nov 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.45 | - | 1 | Aug 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $16.10 | - | 1 | Jul 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.95 | - | 2 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $39.35 | - | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.25 | - | 1 | Jun 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $0.22 | - | 2 | Jul 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $430.12 | - | 2 | Jan 12, 2018 |
Krystal Biotech
Jan 9, 2026
Maintains: Buy
Price Target: $202 → $306
Current: $283.29
Upside: +8.02%
vTv Therapeutics
Jan 5, 2026
Initiates: Buy
Price Target: $67
Current: $37.23
Upside: +79.96%
Insmed
Dec 18, 2025
Maintains: Buy
Price Target: $269 → $241
Current: $151.11
Upside: +59.49%
Palvella Therapeutics
Dec 16, 2025
Maintains: Buy
Price Target: $97 → $133
Current: $79.60
Upside: +67.09%
Milestone Pharmaceuticals
Dec 15, 2025
Upgrades: Buy
Price Target: $8
Current: $1.67
Upside: +379.04%
Praxis Precision Medicines
Dec 8, 2025
Maintains: Buy
Price Target: $251 → $353
Current: $328.93
Upside: +7.32%
Vera Therapeutics
Dec 5, 2025
Maintains: Buy
Price Target: $60 → $73
Current: $44.07
Upside: +65.65%
Avidity Biosciences
Oct 29, 2025
Downgrades: Hold
Price Target: $78 → $74
Current: $72.83
Upside: +1.61%
ACADIA Pharmaceuticals
Sep 11, 2025
Maintains: Buy
Price Target: $35 → $39
Current: $23.19
Upside: +68.18%
Madrigal Pharmaceuticals
Aug 26, 2025
Maintains: Buy
Price Target: $390 → $554
Current: $491.49
Upside: +12.72%
Nov 18, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.33
Upside: -
Nov 18, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.03
Upside: -
Oct 21, 2024
Maintains: Buy
Price Target: $282 → $371
Current: $332.68
Upside: +11.52%
Aug 8, 2023
Initiates: Outperform
Price Target: n/a
Current: $5.25
Upside: -
Mar 22, 2023
Maintains: Outperform
Price Target: $125 → $175
Current: $18.38
Upside: +852.12%
Nov 23, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $53.48
Upside: -
Aug 23, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.45
Upside: -
Jul 20, 2021
Initiates: Outperform
Price Target: n/a
Current: $16.10
Upside: -
Jul 13, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.95
Upside: -
Mar 2, 2021
Initiates: Outperform
Price Target: n/a
Current: $39.35
Upside: -
Jun 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.25
Upside: -
Jul 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $0.22
Upside: -
Jan 12, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $430.12
Upside: -